SCHEMBL19164335

SCHEMBL19164335

N#Cc1ccc(-c2cc(-c3ccccc3)nc(-c3ccc4c(c3)-c3ccccc3-c3ccccc3C43c4ccccc4-c4ccccc43)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 6/20 0.47
▸ KDM4E B2RXH2 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PDK2 Q15119 2/20 0.43
▸ MYC P01106 1/20 0.43
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ GABRA1 P14867 1/20 0.42
▸ GABRG2 P18507 1/20 0.42
▸ GABRB3 P28472 1/20 0.42
▸ GABRA5 P31644 1/20 0.42
▸ GABRA3 P34903 1/20 0.42
▸ ABCB1 P08183 3/20 0.41
▸ MAOB P27338 2/20 0.40
▸ ALDH1A3 P47895 1/20 0.40
▸ NTSR1 P30989 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19164589 0.99 ABCG2 (0.46) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19172916 0.97 PDK2 (0.45) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19164136 0.96 ABCG2 (0.49) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19164392 0.96 ABCG2 (0.49) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19164432 0.95 ABCG2 (0.48) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19164402 0.95 ABCG2 (0.48) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19172302 0.94 ABCG2 (0.48) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19164048 0.94 ABCG2 (0.45) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19172256 0.93 PDK2 (0.49) ABCG2KDM4ELMNASMN1; SMN2PDK2
SCHEMBL19164552 0.92 ABCG2 (0.46) ABCG2KDM4ELMNASMN1; SMN2PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-07-27 — — US disclosed
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME OR51E2, OR10J3, ESR1 ABCG2 2072/4885KDM4E 915/4885LMNA 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback